Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care : I-MOVE-COVID-19 project, Europe, December 2020 to May 2021

Autor: Kissling, Esther, Hooiveld, Mariette, Sandonis Martín, Virginia, Martínez-Baz, Iván, William, Naoma, Vilcu, Ana-Maria, Mazagatos, Clara, Domegan, Lisa, de Lusignan, Simon, Meijer, Adam, Machado, Ausenda, Brytting, Mia, Casado, Itziar, Murray, Josephine-L K., Belhillil, Sylvie, Larrauri, Amparo, O’Donnell, Joan, Tsang, Ruby, de Lange, Marit, Rodrigues, Ana Paula, Riess, Maximilian, Castilla, Jesús, Hamilton, Mark, Falchi, Alessandra, Pozo, Francisco, Dunford, Linda, Cogdale, Jade, Jansen, Tessa, Guiomar, Raquel, Enkirch, Theresa, Burgui, Cristina, Sigerson, Debbie, Blanchon, Thierry, Martínez Ochoa, Eva María, Connell, Jeff, Ellis, Joanna, van Gageldonk-Lafeber, Rianne, Kislaya, Irina, Rose, Angela MC, Valenciano, Marta, Andrews, Nick, Lopez Bernal, Jamie, Whitaker, Heather, Guerrisi, Caroline, Launay, Titouan, Masse, Shirley, van der Werf, Sylvie, Enouf, Vincent, Cuddihy, John, McKenna, Adele, Joyce, Michael, de Gascun, Cillian, Moran, Joanne, Miqueleiz, Ana, Navascués, Ana, Trobajo-Sanmartín, Camino, Ezpeleta, Carmen, Moreno, Paula López, Gorricho, Javier, Ardanaz, Eva, Baigorria, Fernando, Barricarte, Aurelio, de la Cruz, Enrique, Egüés, Nerea, García Cenoz, Manuel, Guevara, Marcela, Moreno-Iribas, Conchi, Sayón, Carmen, Gomez, Verónica, Nunes, Baltazar, Roquete, Rita, Silva, Adriana, Melo, Aryse, Costa, Inês, Verdasca, Nuno, Conde, Patrícia, Marques, Diogo FP, Molesworth, Anna, Quinn, Leanne, Leyton, Miranda, Campbell, Selin, Thoulass, Janine, McMenamin, Jim, Mateo, Ana Martínez, Basile, Luca, Castrillejo, Daniel, Quiñones Rubio, Carmen, Delgado-Sanz, Concepción, Oliva., Jesús

Publikováno v: Eurosurveillance
Eurosurveillance, 2021, 26 (29), ⟨10.2807/1560-7917.ES.2021.26.29.2100670⟩
Repisalud
Instituto de Salud Carlos III (ISCIII)

I-MOVE-COVID-19 primary care study team (in addition to authors above): Nick Andrews, Jamie Lopez Bernal, Heather Whitaker, Caroline Guerrisi, Titouan Launay, Shirley Masse, Sylvie van der Werf, Vincent Enouf, John Cuddihy, Adele McKenna, Michael Joy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20d50b7a98a96418991481d236a3f006
https://hdl.handle.net/10023/26062

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.

Autor: Rose AM; Epiconcept, Paris, France., Nicolay N; European Centre for Disease Prevention and Control, Stockholm, Sweden., Sandonis Martín V; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain., Mazagatos C; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Petrović G; Croatian Institute of Public Health, Zagreb, Croatia., Baruch J; IDCU within Health promotion and disease prevention Directorate, G'mangia, Malta., Denayer S; Sciensano, Brussels, Belgium., Seyler L; Universitair Ziekenhuis Brussel, Brussels, Belgium., Domegan L; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland., Launay O; Inserm, CIC Cochin-Pasteur, Paris, France.; AP-HP, Hôpital Cochin, Paris, France.; Faculty of Medicine, University of Paris City, Paris, France., Machado A; National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal., Burgui C; Instituto de Salud Pública de Navarra-IdiSNA, Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Vaikutyte R; Lithuanian University of Health Sciences, Kaunas, Lithuania., Niessen FA; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Loghin II; St. Parascheva Clinical Hospital of Infectious Diseases, Iasi, Romania.; Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania., Husa P; Faculty of Medicine, Masaryk University, Brno, Czechia.; University Hospital Brno, Brno, Czechia., Aouali N; Luxembourg Institute of Health, Luxembourg., Panagiotakopoulos G; National Public Health Organisation (EODY), Athens, Greece., Tolksdorf K; Robert Koch Institute, Berlin, Germany., Horváth JK; National Laboratory for Health Security, Epidemiology and Surveillance Centre, Semmelweis University, Budapest, Hungary., Howard J; Epiconcept, Paris, France., Pozo F; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain., Gallardo V; Dirección General de Salud Pública y Ordenación Farmacéutica, Junta de Andalucía, Spain., Nonković D; Teaching Public Health Institute of Split-Dalmatia County, Split, Croatia., Džiugytė A; IDCU within Health promotion and disease prevention Directorate, G'mangia, Malta., Bossuyt N; Sciensano, Brussels, Belgium., Demuyser T; Universitair Ziekenhuis Brussel, Brussels, Belgium., Duffy R; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland., Luong Nguyen LB; AP-HP, Hôpital Cochin, Paris, France., Kislaya I; National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal., Martínez-Baz I; Instituto de Salud Pública de Navarra-IdiSNA, Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Gefenaite G; Faculty of Medicine, Lund University, Lund, Sweden.; Lithuanian University of Health Sciences, Kaunas, Lithuania., Knol MJ; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Popescu C; Dr Victor Babes Clinical Hospital of Infectious and Tropical Diseases, Bucharest, Romania.; Carol Davila University of Medicine and Pharmacy, Bucharest, Romania., Součková L; University Hospital Brno, Brno, Czechia., Simon M; Centre Hospitalier de Luxembourg, Luxembourg., Michelaki S; National Public Health Organisation (EODY), Athens, Greece., Reiche J; Robert Koch Institute, Berlin, Germany., Ferenczi A; National Laboratory for Health Security, Epidemiology and Surveillance Centre, Semmelweis University, Budapest, Hungary., Delgado-Sanz C; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Lovrić Makarić Z; Croatian Institute of Public Health, Zagreb, Croatia., Cauchi JP; IDCU within Health promotion and disease prevention Directorate, G'mangia, Malta., Barbezange C; Sciensano, Brussels, Belgium., Van Nedervelde E; Universitair Ziekenhuis Brussel, Brussels, Belgium., O'Donnell J; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland., Durier C; Inserm, US19, Villejuif, Paris, France., Guiomar R; National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal., Castilla J; Instituto de Salud Pública de Navarra-IdiSNA, Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Jonikaite I; Lithuanian University of Health Sciences, Kaunas, Lithuania., Bruijning-Verhagen PC; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Lazar M; 'Cantacuzino' National Military Medical Institute for Research-Development, Bucharest, Romania., Demlová R; Faculty of Medicine, Masaryk University, Brno, Czechia., Wirtz G; Centre Hospitalier de Luxembourg, Luxembourg., Amerali M; National Public Health Organisation (EODY), Athens, Greece., Dürrwald R; Robert Koch Institute, Berlin, Germany., Kunstár MP; National Laboratory for Health Security, Epidemiology and Surveillance Centre, Semmelweis University, Budapest, Hungary., Kissling E; Epiconcept, Paris, France., Bacci S; European Centre for Disease Prevention and Control, Stockholm, Sweden., Valenciano M; Epiconcept, Paris, France.

Publikováno v: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2023 Nov; Vol. 28 (47).

Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021.

Autor: Kissling E; Epiconcept, Paris, France., Hooiveld M; Nivel, Utrecht, the Netherlands., Martínez-Baz I; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Mazagatos C; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain., William N; Public Health Scotland, Glasgow, United Kingdom., Vilcu AM; INSERM, Sorbonne Université, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France., Kooijman MN; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Ilić M; Croatian Institute of Public Health, Zagreb, Croatia., Domegan L; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland., Machado A; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal., de Lusignan S; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.; Royal College of General Practitioners Research and Surveillance Centre, London, United Kingdom., Lazar M; 'Cantacuzino' National Military Medical Institute for Research and Development, Bucharest, Romania., Meijer A; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Brytting M; The Public Health Agency of Sweden, Stockholm, Sweden., Casado I; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Larrauri A; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain., Murray JK; Public Health Scotland, Glasgow, United Kingdom., Behillil S; Unité de Génétique Moléculaire des Virus à ARN, UMR 3569 CNRS, Université Paris Diderot SPC, Institut Pasteur, Paris, France.; CNR des virus des infections respiratoires, Institut Pasteur, Paris, France., de Gier B; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Mlinarić I; Croatian Institute of Public Health, Zagreb, Croatia., O'Donnell J; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland., Rodrigues AP; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal., Tsang R; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.; Royal College of General Practitioners Research and Surveillance Centre, London, United Kingdom., Timnea O; 'Cantacuzino' National Military Medical Institute for Research and Development, Bucharest, Romania., de Lange M; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Riess M; The Public Health Agency of Sweden, Stockholm, Sweden., Castilla J; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Pozo F; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain., Hamilton M; Public Health Scotland, Glasgow, United Kingdom., Falchi A; Laboratoire de Virologie, Université de Corse-Inserm, Corte, France., Knol MJ; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Kurečić Filipović S; Croatian Institute of Public Health, Zagreb, Croatia., Dunford L; National Virus Reference Laboratory, University College Dublin, Dublin, Ireland., Guiomar R; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal., Cogdale J; UK Health Security Agency, United Kingdom., Cherciu C; 'Cantacuzino' National Military Medical Institute for Research and Development, Bucharest, Romania., Jansen T; Nivel, Utrecht, the Netherlands., Enkirch T; The Public Health Agency of Sweden, Stockholm, Sweden., Basile L; Subdirección General de Vigilancia y Respuesta a Emergencias de Salud Pública, Agencia de Salud Pública, Catalunya, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Connell J; National Virus Reference Laboratory, University College Dublin, Dublin, Ireland., Gomez V; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal., Sandonis Martín V; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain., Bacci S; European Centre for Disease Prevention and Control, Stockholm, Sweden., Rose AM; Epiconcept, Paris, France., Pastore Celentano L; European Centre for Disease Prevention and Control, Stockholm, Sweden., Valenciano M; Epiconcept, Paris, France.

Publikováno v: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2022 May; Vol. 27 (21).